bitertanol has been researched along with Chromoblastomycosis in 1 studies
*Chromoblastomycosis: Scaly papule or warty growth, caused by five fungi, that spreads as a result of satellite lesions affecting the foot or leg. The extremity may become swollen and, at its distal portion, covered with various nodular, tumorous, verrucous lesions that resemble cauliflower. In rare instances, the disease may begin on the hand or wrist and involve the entire upper extremity. (Arnold, Odom, and James, Andrew's Diseases of the Skin, 8th ed, p362) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida-Paes, R; Alves, GM; Amaral, ACF; Brito-Santos, F; Coelho, RA; Figueiredo-Carvalho, MHG; Joffe, LS; Rodrigues, ML | 1 |
1 other study(ies) available for bitertanol and Chromoblastomycosis
| Article | Year |
|---|---|
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis.
Topics: Acetates; Antifungal Agents; Ascomycota; Auranofin; Biphenyl Compounds; Chromoblastomycosis; Dioxolanes; Drug Synergism; Exophiala; Fungi; Humans; Imines; Iodoquinol; Pyrimidines; Strobilurins; Triazoles | 2020 |